Human Genome Epidemiology Literature Finder
Records 1 - 3 (of 3 Records) |
Query Trace: Lung Neoplasms and DCK[original query] |
---|
Population pharmacokinetics of gemcitabine and its metabolite in Japanese cancer patients: impact of genetic polymorphisms. Clinical pharmacokinetics 2010 Aug 49 (8): 549-58. Sugiyama Emiko, Kaniwa Nahoko, Kim Su-Ryang, Hasegawa Ryuichi, Saito Yoshiro, Ueno Hideki, Okusaka Takuji, Ikeda Masafumi, Morizane Chigusa, Kondo Shunsuke, Yamamoto Noboru, Tamura Tomohide, Furuse Junji, Ishii Hiroshi, Yoshida Teruhiko, Saijo Nagahiro, Sawada Jun-Ic |
Lack of association of genetic variations of deoxycytidine kinase with toxicity or survival of non-small-cell lung cancer patients treated with gemcitabine plus cisplatin. Oncology research 2012 20 (1): 1. Ryu JS, Kim HJ, Shin ES, Nam HS, Cho JH, Lee JE |
Reproducibility of pharmacogenetics findings for paclitaxel in a heterogeneous population of patients with lung cancer. PloS one 2019 3 14 (2): e0212097. Sissung Tristan M, Rajan Arun, Blumenthal Gideon M, Liewehr David J, Steinberg Seth M, Berman Arlene, Giaccone Giuseppe, Figg William |
- Page last reviewed:Feb 1, 2024
- Content source: